108 related articles for article (PubMed ID: 8184639)
1. GUSTO, TIMI and the case for rapid reperfusion.
Cannon CP; Braunwald E
Acta Cardiol; 1994; 49(1):1-8. PubMed ID: 8184639
[No Abstract] [Full Text] [Related]
2. Differential effects of tissue plasminogen activator and streptokinase on infarct size and on rate of enzyme release: influence of early infarct related artery patency. The GUSTO Enzyme Substudy.
Baardman T; Hermens WT; Lenderink T; Molhoek GP; Grollier G; Pfisterer M; Simoons ML
Eur Heart J; 1996 Feb; 17(2):237-46. PubMed ID: 8732377
[TBL] [Abstract][Full Text] [Related]
3. The GUSTO trial: is the open-artery hypothesis proven?
Stringer KA; Lindenfeld J
Ann Pharmacother; 1994 Jan; 28(1):97-8. PubMed ID: 8123971
[No Abstract] [Full Text] [Related]
4. Early patency in acute myocardial infarction.
Belenkie I
Can J Cardiol; 1993 Mar; 9(2):149-51. PubMed ID: 8490781
[No Abstract] [Full Text] [Related]
5. Future directions in thrombolysis for myocardial infarction: what are the unanswered questions?
Lefkovits J; Topol EJ
Coron Artery Dis; 1994 Apr; 5(4):306-16. PubMed ID: 8044342
[No Abstract] [Full Text] [Related]
6. Association between admission mean platelet volume and coronary patency after thrombolytic therapy for acute myocardial infarction.
Yaşar AS; Bilen E; Yüksel IO; Arslantaş U; Karakaş F; Kirbaş O; Bilge M
Turk Kardiyol Dern Ars; 2010 Mar; 38(2):85-9. PubMed ID: 20473008
[TBL] [Abstract][Full Text] [Related]
7. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction.
GUSTO Angiographic Investigators
N Engl J Med; 1993 Nov; 329(22):1615-22. PubMed ID: 8232430
[TBL] [Abstract][Full Text] [Related]
8. "Rescue" thrombolysis with intracoronary tissue plasminogen activator for failed intravenous thrombolysis with streptokinase for acute myocardial infarction.
White HD; Cross DB; Williams BF; Norris RM; Woo KS; Hamer AW; Elliott JM; Ormiston JA
Am J Cardiol; 1995 Jan; 75(2):172-4. PubMed ID: 7810496
[No Abstract] [Full Text] [Related]
9. Thrombolytic therapy for myocardial infarction: a perspective of clinical trialists. The GUSTO Investigators.
Califf RM; Topol EJ
Clin Cardiol; 1992 Mar; 15(3):143-4. PubMed ID: 1551260
[No Abstract] [Full Text] [Related]
10. GUSTO (Global Utilization of Streptokinase and Tissue plasminogen activator in Occluded arteries): logic wins at last.
Bassand JP
Eur Heart J; 1994 Jan; 15(1):2-4. PubMed ID: 8174579
[No Abstract] [Full Text] [Related]
11. Enrolment in trials of thrombolysis.
Geraci E
Lancet; 1990 Oct; 336(8722):1069-70. PubMed ID: 1977042
[No Abstract] [Full Text] [Related]
12. Long term effects of thrombolytic therapy in acute myocardial infarction.
Shah LS
J Assoc Physicians India; 1994 Jan; 42(1):9-11. PubMed ID: 7836276
[No Abstract] [Full Text] [Related]
13. [Tissue plasminogen activator is the best thrombolytic agent].
Bates E
Arq Bras Cardiol; 1994 Jul; 63(1):57-8. PubMed ID: 7857215
[No Abstract] [Full Text] [Related]
14. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators.
Weaver WD; White HD; Wilcox RG; Aylward PE; Morris D; Guerci A; Ohman EM; Barbash GI; Betriu A; Sadowski Z; Topol EJ; Califf RM
JAMA; 1996 Mar; 275(10):777-82. PubMed ID: 8598594
[TBL] [Abstract][Full Text] [Related]
15. Thrombolytic therapy of myocardial infarction--it's time for science, not marketing: the perspective of a practicing cardiologist.
Vogel JH
Clin Cardiol; 1991 Jul; 14(7):548. PubMed ID: 1810292
[No Abstract] [Full Text] [Related]
16. TIMI grade flow, mortality, and the GUSTO-III trial.
Stringer KA
Pharmacotherapy; 1998; 18(4):699-705. PubMed ID: 9692644
[TBL] [Abstract][Full Text] [Related]
17. Does intravenous heparin or time-to-treatment/reperfusion explain differences between GUSTO and ISIS-3 results?
Anderson JL; Karagounis LA
Am J Cardiol; 1994 Nov; 74(10):1057-60. PubMed ID: 7977047
[No Abstract] [Full Text] [Related]
18. More on the GUSTO Trial.
Lomaestro BM
Ann Intern Med; 1994 Nov; 121(10):818-9. PubMed ID: 7944069
[No Abstract] [Full Text] [Related]
19. Breaking the thrombolytic gridlock: insights from the GUSTO trial.
Topol EJ
Cleve Clin J Med; 1993; 60(6):445-7. PubMed ID: 8287504
[No Abstract] [Full Text] [Related]
20. Global utilization of streptokinase and tPA for occluded arteries (GUSTO) ECG-monitoring substudy. Study design and technical considerations.
Krucoff MW; Green CL; Langer A; Klootwijk LJ; Trollinger KM; Sawchak ST; Wilderman NM; Veldkamp RF; Pope JE; Simoons ML
J Electrocardiol; 1993; 26 Suppl():249-55. PubMed ID: 8189133
[No Abstract] [Full Text] [Related]
[Next] [New Search]
